The human body constantly generates a variety of signals that can be measured from outside the body with wearable devices[1]. These bio-signals – ranging from heart rate to sleep state and blood oxygen levels – can indicate whether someone is having mood swings[2] or can be used to diagnose a variety of body[3] or brain disorders[4].

It can be relatively cheap to gather a lot of bio-signal data. Researchers can organize...

Read more

A new study has found that certain bacteria living in the nose may influence how likely someone is to get a COVID-19 infection. The research reveals that certain types of nasal bacteria can affect the levels of key proteins the virus needs to enter human cells, offering new insight into why some people are more vulnerable to COVID-19 than others.

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient recruitment for the phase 1 trial will begin soon (NCT06913608). The phase 1 clinical trial will evaluate the safety and efficacy of CLBR001 + SWI019 in patients with myositis, systemic sclerosis, lupus and rheumatoid arthritis, with the potential to expand to other indications in the future.

More Articles …